Marshall Financial Group LLC Bio Rad Laboratories, Inc. Transaction History

Marshall Financial Group LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 25, 2022	SELL	$463.67 - $597.16 $554,549 - $714,203	-1,196 Closed	0 $0
Q1 2022 May 10, 2022	SELL	$524.57 - $735.42 $15,737 - $22,062	-30 Reduced 2.45%	1,196 $674,000
Q4 2021 Jan 27, 2022	BUY	$708.84 - $794.68 $111,996 - $125,559	158 Added 14.79%	1,226 $926,000
Q3 2021 Oct 28, 2021	BUY	$657.71 - $825.77 $48,670 - $61,106	74 Added 7.44%	1,068 $797,000
Q2 2021 Jul 14, 2021	BUY	$576.64 - $649.04 $573,180 - $645,145	994 New	994 $640,000

489

17.8M

44.9K

79.7K

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $6.65B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

Get notified when there are updates to the investment portfolio of Marshall Financial Group LLC, based on Form 13F filings with the SEC.

Stay updated on Marshall Financial Group LLC with notifications on news.